Chemotherapy Anti-Emetic for Oncology and Haematology Guideline CA4044 v3.1
The purpose of this document is to provide guidance on the use of antiemetics for prevention and treatment of chemotherapy CT and radiotherapy RT induced nausea and vomiting N&V in adult patients. It is not intended to address N&V in palliative care. It is intended to provide a framework to support clinical practice it can not cover every clinical situation and good common clinical sense and clinical experience will be required when approaching the management of individual patients.
Clinical GuidelinesThis guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.
The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.